Signalling mechanisms and cellular functions of SUMO

ACO Vertegaal - Nature Reviews Molecular Cell Biology, 2022 - nature.com
Sumoylation is an essential post-translational modification that is catalysed by a small
number of modifying enzymes but regulates thousands of target proteins in a dynamic …

SUMO and the robustness of cancer

JS Seeler, A Dejean - Nature Reviews Cancer, 2017 - nature.com
Post-translational protein modification by small ubiquitin-like modifier (SUMO), termed
sumoylation, is an important mechanism in cellular responses to stress and one that …

[HTML][HTML] The post-translational modification, SUMOylation, and cancer

ZJ Han, YH Feng, BH Gu, YM Li… - … journal of oncology, 2018 - spandidos-publications.com
SUMOylation is a reversible post-translational modification which has emerged as a crucial
molecular regulatory mechanism, involved in the regulation of DNA damage repair, immune …

Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts

AB Celen, U Sahin - The FEBS journal, 2020 - Wiley Online Library
Sumoylation is an essential post‐translational modification intimately involved in a diverse
range of eukaryotic cellular mechanisms. Small ubiquitin‐like modifier (SUMO) protein …

SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs

G Hou, X Zhao, L Li, Q Yang, X Liu… - Nucleic acids …, 2021 - academic.oup.com
Abstract N 6-Methyladenosine (m6A) is the most abundant modification within diverse RNAs
including mRNAs and lncRNAs and is regulated by a reversible process with important …

Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor

X He, J Riceberg, T Soucy, E Koenig… - Nature chemical …, 2017 - nature.com
Small ubiquitin-like modifier (SUMO) family proteins regulate target-protein functions by post-
translational modification. However, a potent and selective inhibitor targeting the SUMO …

Targeting SUMO signaling to wrestle cancer

JS Kroonen, ACO Vertegaal - Trends in cancer, 2021 - cell.com
The small ubiquitin-like modifier (SUMO) signaling cascade is critical for gene expression,
genome integrity, and cell cycle progression. In this review, we discuss the important role …

Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model

S Kumar, MJA Schoonderwoerd, JS Kroonen… - Gut, 2022 - gut.bmj.com
Objective Pancreatic ductal adenocarcinoma (PDAC) has the characteristics of high-density
desmoplastic stroma, a distinctive immunosuppressive microenvironment and is profoundly …

Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer

UM Demel, M Böger, S Yousefian… - The Journal of …, 2022 - Am Soc Clin Investig
Activated SUMOylation is a hallmark of cancer. Starting from a targeted screening for SUMO-
regulated immune evasion mechanisms, we identified an evolutionarily conserved function …

E1 enzymes as therapeutic targets in cancer

SH Barghout, AD Schimmer, E Barker - Pharmacological reviews, 2021 - Elsevier
Post-translational modifications of cellular substrates with ubiquitin and ubiquitin-like
proteins (UBLs), including ubiquitin, SUMOs, and neural precursor cell–expressed …